Befar Group (601678) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Oct, 2026Executive summary
2025 revenue rose 45.06% to RMB 14.84bn, while net income attributable to shareholders increased 2.75% to RMB 225.3m; operating cash flow strengthened sharply to RMB 2.87bn.
Growth was driven mainly by the C3/C4 complex ramp-up and higher PO and MTBE volumes; lower raw-material and energy costs supported product gross profit.
Q4 revenue was RMB 3.69bn, attributable net income RMB 33.0m, adjusted net income RMB 14.9m, and operating cash flow RMB 1.38bn.
Financial highlights
Revenue reached RMB 14.84bn, up 45.06% YoY; operating costs rose 40.39% to RMB 13.31bn.
Profit before tax was RMB 342.8m; net income attributable to shareholders was RMB 225.3m, up 2.75% YoY.
Excluding non-recurring items, attributable net income was RMB 110.7m, down 49.33% YoY; non-recurring gains totaled RMB 114.6m.
Operating cash flow increased to RMB 2.87bn from RMB 486.1m; investing cash outflow narrowed to RMB 727.1m, while financing cash flow was an outflow of RMB 891.0m.
Research and development expense rose 43.95% to RMB 173.2m; adjusted net income excluding share-based payment expenses was RMB 256.3m, up 33.93%.
Outlook and guidance
2026 production targets include caustic soda 780,000 tonnes, propylene oxide 549,300 tonnes, MTBE 683,800 tonnes, and electronic-grade hydrofluoric acid 6,600 tonnes.
Priorities include completing the C4 downstream integration project startup, advancing the 240,000-tonne polyether polyol project, and targeting handover of the Yangxin electronic chemicals base by year-end.
Plans include progressing a 260MW integrated source-grid-load-storage project toward wind-power grid connection and building a 20,000-tonne caustic soda project.
Strategic priorities include technology-led growth, operational cost control, overseas expansion, and pursuing an H-share listing to create an A+H financing platform.
Latest events from Befar Group
- Revenue surged, but higher costs and weak chemical prices cut H1 net income 29.85%.601678
Q2 2024 - PDH-fueled revenue growth met sharply lower profit amid price and margin pressure.601678
Q4 2024 - Q3 sales rose with project ramp-up, while 9M profit weakened amid higher costs and lower prices.601678
Q3 2024 - New PO/MTBE capacity drove strong sales growth, but adjusted H1 earnings remained negative.601678
Q2 2025 - Q1 revenue rose 94.14%; attributable profit rose 225.75% as new projects ramped.601678
Q1 2025 - Project ramp-up lifted revenue and profit, while Q3 parent net income dipped.601678
Q3 2025 - Higher product prices drove a sharp H1 profit rebound; the H-share listing funded expansion.601678
Q2 2026 - Q1 profit rose sharply, while operating cash flow fell 80.56%.601678
Q1 2026